Immuron FY23 Sales increase 136% on FY22 Sales

Stock Information for Immuron Limited

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Immuron Limited

Immuron Travelan® highest sales in history
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)
Presenting on the Emerging Growth Conference 79 Day 1 on February 18 Register Now
Immuron Travelan® continued strong sales growth
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
Immuron Announces Travelan® Clinical Trial Update
UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.